Saturday, Sep 12, 2026

"bristol-myers-squibb"

Sun Pharma settles patent dispute with US Celgene Corporation

In addition, the license will also allow Sun Pharma to manufacture and sell an unlimited quantity of generic lenalidomide capsules in the US beginning January 31, 2026.

Latest News

Pezeshkian in Delhi: Iran won’t surrender to oppression

34 seconds ago
Trump vows Iran will never get nuclear weapons at 9/11 anniversary

9 minutes ago
BTPS chief engineer gheraoed by TGPE JAC leaders over YTPS privatisation move

52 minutes ago
Not all MoUs signed with investors materialise, admits Industries Minister Sridhar Babu

59 minutes ago
BVRIT hosts FAILATHON to foster innovation, culture of learning from failure

1 hour ago
Farmers drying paddy at Siddipet IT tower: BJP MLA tells Assembly

1 hour ago
From aspiring golfer to coach, Sanjay Singh eyes more success stories

1 hour ago
Ex-Kasipet Tahsildar jailed for accepting bribe

1 hour ago